Researchers from Duke University have developed a biopolymer that could provide weeks of glucose control for patients with diabetes – in a single injection.
The controlled-release treatment lasted for weeks in primates, according to a study published in Nature Biomedical Engineering. The biomedical engineers suggested that this new, injectable solution could replace daily or weekly insulin shots for people with Type II diabetes.
Get the full story at our sister site, Drug Delivery Business News.
The post Biopolymer tested as long-acting glucose control therapy appeared first on MassDevice.